tiprankstipranks
Heart Test Laboratories, Inc. (HSCS)
NASDAQ:HSCS
US Market

Heart Test Laboratories, Inc. (HSCS) Stock Forecast & Price Target

107 Followers
See the Price Targets and Ratings of:

HSCS Analyst Ratings

Currently, no data available
Based on 0 analysts giving stock ratings to
Heart
Test Laboratories, Inc.
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

HSCS Stock 12 Month Forecast

There Are No Analyst Ratings for HSCS In The Last 3 Months.
Highest Price TargetAverage Price TargetLowest Price Target
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

HSCS Financial Forecast

HSCS Earnings Forecast

Next quarter’s earnings estimate for HSCS is -$3.50 with a range of -$4.00 to -$3.00. The previous quarter’s EPS was -$3.00. HSCS beat its EPS estimate 50.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 57.28% of the time in the same period. In the last calendar year HSCS has Underperformed its overall industry.
Next quarter’s earnings estimate for HSCS is -$3.50 with a range of -$4.00 to -$3.00. The previous quarter’s EPS was -$3.00. HSCS beat its EPS estimate 50.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 57.28% of the time in the same period. In the last calendar year HSCS has Underperformed its overall industry.

HSCS Sales Forecast

Next quarter’s sales forecast for HSCS is $50.00K with a range of $0.00 to $100.00K. The previous quarter’s sales results were $14.70K. HSCS beat its sales estimates 50.00% of the time in past 12 months, while its overall industry beat sales estimates 46.71% of the time in the same period. In the last calendar year HSCS has Outperformed its overall industry.
Next quarter’s sales forecast for HSCS is $50.00K with a range of $0.00 to $100.00K. The previous quarter’s sales results were $14.70K. HSCS beat its sales estimates 50.00% of the time in past 12 months, while its overall industry beat sales estimates 46.71% of the time in the same period. In the last calendar year HSCS has Outperformed its overall industry.

Detailed List of Analyst Forecasts​

Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Maxim Group
$300$35
Buy
693.65%
Upside
Reiterated
03/18/24
Heart Test Laboratories price target lowered to 35c from $3 at MaximHeart Test Laboratories price target lowered to 35c from $3 at Maxim
Ascendiant
$90
Buy
1940.82%
Upside
Reiterated
12/22/23
We are lowering our FY24 revenue estimate to $0.1 million (from $0.4 million previously) and leaving our FY25 revenue estimate unchanged at $5.4 million, in line with consensus. 510K clearance pathway means a streamlined FDA approval process. On Dec 5, HSCS announced that it had received confirmation from the FDA to change the clearance pathway for its MyoVista device and associated algorithms from the relatively complex De Novo pathway to the more standard 510K pathway. This will make it quicker and less expensive for the company to receive FDA clearance for its hardware, as well as the family of algorithms that it inherits from the Mt. Sinai agreement.

Best Analysts Covering Heart Test Laboratories, Inc.

Which Analyst Should I Follow If I Want to Buy HSCS and Sell After:
1 Month
Lucas WardAscendiant
Success Rate
0/5 ratings generated profit
0%
Average Return
-29.32%
reiterated a buy rating 7 months ago
Copying Lucas Ward's trades and holding each position for 1 Month would result in 0.00% of your transactions generating a profit, with an average return of -29.32% per trade.
dummydummy
Success Rate
0/0 ratings generated profit
0%
Average Return
0.00%
a rating ―
Copying dummy's trades and holding each position for XXXX would result in 0.10% of your transactions generating a profit, with an average return of 0.00% per trade.
Premium Content
Find out which analyst has the highest Average Return & Success Rate
Go Premium
3 Months
Lucas WardAscendiant
Success Rate
0/5 ratings generated profit
0%
Average Return
-45.98%
reiterated a buy rating 7 months ago
Copying Lucas Ward's trades and holding each position for 3 Months would result in 0.00% of your transactions generating a profit, with an average return of -45.98% per trade.
dummydummy
Success Rate
0/0 ratings generated profit
0%
Average Return
0.00%
a rating ―
Copying dummy's trades and holding each position for XXXX would result in 0.10% of your transactions generating a profit, with an average return of 0.00% per trade.
Premium Content
Find out which analyst has the highest Average Return & Success Rate
Go Premium
1 Year
Lucas WardAscendiant
Success Rate
0/5 ratings generated profit
0%
Average Return
-88.22%
reiterated a buy rating 7 months ago
Copying Lucas Ward's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -88.22% per trade.
2 Years
Lucas WardAscendiant
Success Rate
0/5 ratings generated profit
0%
Average Return
-90.56%
reiterated a buy rating 7 months ago
Copying Lucas Ward's trades and holding each position for 2 Years would result in 0.00% of your transactions generating a profit, with an average return of -90.56% per trade.
dummydummy
Success Rate
0/0 ratings generated profit
0%
Average Return
0.00%
a rating ―
Copying dummy's trades and holding each position for XXXX would result in 0.10% of your transactions generating a profit, with an average return of 0.00% per trade.
Premium Content
Find out which analyst has the highest Average Return & Success Rate
Go Premium
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

HSCS Analyst Recommendation Trends

Rating
Mar 23
Aug 23
Oct 23
Dec 23
Mar 24
Strong Buy
0
1
2
3
3
Buy
3
2
1
0
0
Hold
0
0
0
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
3
3
3
3
3
In the current month, HSCS has received 3 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. HSCS average Analyst price target in the past 3 months is .
Each month's total comprises the sum of three months' worth of ratings.
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

HSCS Stock Forecast FAQ

What is HSCS’s average 12-month price target, according to analysts?
Currently, no data Available
What is HSCS’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for HSCS, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
    How can I follow the stock ratings of top Wall Street analysts?
    Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
      Is HSCS a Buy, Sell or Hold?
      Currently, no data Available
      What is Heart Test Laboratories, Inc.’s price target?
      Currently, no data Available
      What do analysts say about Heart Test Laboratories, Inc.?
      Not enough analysts have published a price target to provide an average price target.
      How can I buy shares of HSCS?
      Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.
        What's Included in PREMIUM?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis